Tumor Antigens
The immune system plays a role in surveillance of neoplastic cells that have escaped controls on proliferation. Some tumors have tumor-specific antigens on their surfaces. (These antigens are also called TSA, tumor-specific transplantation antigens, TSTA, tumor rejection antigens, or TRA.) TSA are absent on non-tumor cells, and typically appear after an infecting virus has caused the cell to express viral antigens and to escape controls (become immortal). Some TSAs are not induced by viruses, but are the idiotypes of BCR on B cell lymphomas or TCR on T cell lymphomas. | ||
Antigen | Function of Antigen | Expressed on |
Cyclin-dependent kinase 4 | Cell cycle regulator | Melanoma |
β-catenin | Signal transduction | Melanoma |
Caspase-8 | Apoptosis regulator | Squamous cell carcinoma |
MAGE-1MAGE-3 | Normal testicular proteins | Melanoma, breast, glioma tumors; |
Tyrosinase | Melanin synthesis | Melanoma |
Surface Ig idiotype | BCR | Lymphoma |
Her-2/neu | Receptor tyrosine kinase | Breast and ovarian cancer |
MUC-1 | Underglycosylated mucin | Breast and pancreatic tumors |
HPV E6 and E7 | Viral gene products | Cervical carcinoma |
Attempts have been made to kill tumor cells employ by linking tumor-specific antibodies to toxins, anti-tumor drugs, or very energetic radioisotopes. Problems with such therapies include the time-consuming and expensive necessity of making a unique antibody for each tumor, the lack of antibody access to the tumor center, and human-anti-mouse-antibody (HAMA) responses to xenogeneic monoclonal antibodies. Although production of human monoclonals has proved difficult, chimeric antibodies and humanized antibodies can be made that are less immunogenic. In a few patients, mAb have induced tumor remission or elimination. | ||
Tumor Antigens Targeted by mAb | ||
Antigen Type | Specific Antigen | Tumor Type |
Differentiation | CD5 Idiotype CAMPATH-1 | T cell lymphoma B cell lymphoma T and B cell lymphomas |
B cell signaling | CD20 | Non-Hodgkin's B cell lymphoma |
Growth factor receptor | Epidermal growth factor receptor p185HER2 IL-2R | Lung, breast, head, and neck tumors Breast, ovarian tumors T and B cell tumors |
Cell surface glycoprotein | CEA, mucin-1 | Epithelial tumors (breast, colon, lung) |
Cell surface carbohydrate | Lewisx, CA-125 | Epithelial tumors Ovarian carcinoma |
Stromal extracellular antigen | FAP-α Tenascin Metalloproteinases | Epithelial tumors Glioblastoma multiforme Epithelial tumors |
Labels: mAb, TRAM, TSA, TSTA, tumor rejection antigens, tumor-specific antigens, tumor-specific transplantation antigens
0 Comments:
Post a Comment
<< Home